Last updated: 2026-09-06 13:19:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Cellebrite DI Ltd (CLBT) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $11.46, with a market capitalization of $2.88B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $9.58 to $19.98. This page covers its latest market performance, valuation, price trends and company information.
$2.88B | |
$11.94 | |
$26.30 | |
$3.80 | |
$11.94 | |
1.64M | |
2.78M | |
-- | |
$19.98 | |
$9.58 | |
-- | |
-- |
Cellebrite DI Ltd (CLBT) last closed at $11.94 as of 2026-09-04 23:57:00, unchanged from the previous close of $11.94.
During the latest regular trading session, CLBT traded between $3.80 and $26.30, with a volume of 1.64M shares. The closing price was near the middle and near the lower end of its 52-week range.
Over the past seven days, Cellebrite DI Ltd (CLBT) moved from $12.29 to $11.46, representing a decline of 6.77% ($0.83).
The stock traded between $11.40 and $12.43 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 2.05 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 18.1%
CLBT is currently trading at $11.46, placing it 18.1% of the way from its 52-week low of $9.58 to its 52-week high of $19.98. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Cellebrite DI Ltd provides AI-powered digital investigative and intelligence solutions that help public and private sector customers transform investigative workflows, make digital data more accessible and actionable, and improve the efficiency of mobile research and application security. Its solutions support law enforcement, defense, and intelligence agencies in advancing investigations, border security, counterterrorism, intelligence operations, and cyber operations. The company's software also enables enterprises and service providers to collect and review data for corporate investigations, eDiscovery, incident response, and mobile application validation. It operates in the Americas, APAC, and EMEA, with the majority of revenue from the Americas.
| Employees | 1285 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Cellebrite DI Ltd (CLBT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.